U.S. CDC Tested
Each Sedia® HIV-1 LAg-Avidity EIA lot is performance tested by both Sedia’s Quality Control Department and by the U.S. Centers for Disease Control prior to market release.
Certification of CDC testing can be provided upon request.
**Parekh B, Duong Y, Mavengere Y, et al. Performance of new LAg-Avidity EIA to measure HIV-1 incidence estimates and avidity maturation studies. PLoS ONE 2012, 7(3):e33328.